Gore Launches TAG Conformable Thoracic Devices With Reduced Profiles in Europe

January 21, 2019 -- Gore & Associates announced the commercial introduction in Europe of reduced profiles for the most commonly used diameters of its TAG conformable thora…

Philips Launches Azurion With FlexArm

January 17, 2019 -- Royal Philips announced the launch of Azurion with FlexArm for image-guided procedures. The Philips Azurion 7 C20 with FlexArm, which has received CE Mark …

FDA Issues Letter on Potential Increased Mortality With Pacilitaxel-Coated Devices in SFA

January 17, 2019 -- On its website, the FDA posted an advisory to peripheral interventionalists and vascular medicine physicians to inform them that the agency is evaluating r…

New Appropriate Use Criteria Address Peripheral Artery Interventions

January 16, 2019 -- The American College of Cardiology (ACC) announced that the "2018 Appropriate Use Criteria for Peripheral Artery Intervention" document was publi…

Study Evaluates Strength of Evidence Underlying the AHA/ACC Guidelines on Treating Peripheral Vascular Disease

January 16, 2019 -- Findings from a study evaluating the evidence base supporting the American Heart Association (AHA)/American College of Cardiology (ACC) guidelines on perip…

Atherectomy Included in Pivotal Study of QT Vascular's Chocolate Touch DCB

January 16, 2019 -- QT Vascular Ltd. announced that the FDA has granted approval to include the use of atherectomy for lesion preparation in its ongoing United States pivotal …

Click here for more News coverage

Current Supplement


Shifting the SFA Treatment Paradigm

Global thought leaders discuss the ELUVIA DES IMPERIAL Trial results and its influence on treatment decisions

Current European Supplement

Sponsored by BIOTRONIK

Maximizing Outcomes. Minimizing Burden.

How to React in the SFA

Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.


Featured Center



Vascular Market Price  Change
Abbott Laboratories $70.87  -0.78%
AstraZeneca PLC $36.22  -0.90%
Avinger $0.30  4.58%
Becton Dickinson and Co $238.92  -1.31%
Boston Scientific Corporation $37.32  -0.98%
Cardinal Health $48.55  -1.02%
Cardiovascular Systems Inc. $28.90  -0.82%
Edwards Lifesciences Corp. $167.98  -0.26%
Endologix Inc. $0.78  -6.53%
Vascular Market Price  Change
Johnson and Johnson $127.69  -2.30%
Medtronic, Inc. $86.59  -0.81%
Merit Medical Systems, Inc. $54.08  0.90%
Penumbra, Inc. $141.69  -0.22%
Philips $35.68  -0.08%
Stryker $166.60  -0.57%
Teleflex Inc. $257.71  -0.08%
The Medicines Company $19.63  -1.85%


Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.